Xavier Cathelineau

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 197 publications

Shifting Risk Profile in Radical Prostatectomy Over 18 Years: A Bicentric French Study of 8,358 Patients.

Shifting Risk Profile in Radical Prostatectomy Over 18 Years: A Bicentric French Study of 8,358 Patients.

Journal: The French journal of urology

Published: May 02, 2026

Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?

Focal Therapy for Prostate Cancer: A Treatment Option Reserved for the Ideal Candi-date?

Journal: International braz j urol : official journal of the Brazilian Society of Urology

Published: March 31, 2026

Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.

Results of the Randomized Phase 3 AFU-GETUG-20 Trial Evaluating Adjuvant Leuprorelin Acetate After Radical Prostatectomy in Men with High-risk Localized Prostate Cancer.

Journal: European urology oncology

Published: October 09, 2025

Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound vs Magnetic Resonance Imaging/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study.

Detection of Clinically Significant Prostate Cancer Using Micro-Ultrasound vs Magnetic Resonance Imaging/Ultrasound Fusion Biopsy: A Propensity-Weighted Comparative Study.

Journal: The Journal of urology

Published: September 26, 2025

Evaluating the Safety of Delaying Surgery Beyond 9 Months in Localized Prostate Cancer Patients: Results From a Prospective Study With Propensity Score Matching.

Evaluating the Safety of Delaying Surgery Beyond 9 Months in Localized Prostate Cancer Patients: Results From a Prospective Study With Propensity Score Matching.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: March 26, 2025

Imaging in focal therapy: advanced ultrasound imaging and mpMRI-a comprehensive review.

Imaging in focal therapy: advanced ultrasound imaging and mpMRI-a comprehensive review.

Journal: Prostate cancer and prostatic diseases

Published: March 25, 2025

Refining partial gland ablation for localised prostate cancer: the FALCON project.

Refining partial gland ablation for localised prostate cancer: the FALCON project.

Journal: BJU international

Published: July 21, 2024

The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review.

The role of androgen deprivation therapy prior to radical prostatectomy in high-risk prostate cancer: a systematic review.

Journal: Minerva urology and nephrology

Published: May 14, 2024

Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal Status.

Final Results of the ANDROCAN Study: Histopathological Characteristics and Biochemical Recurrence at 5 Years of Localized Prostate Cancer According to Preoperative Gonadal Status.

Journal: European urology oncology

Published: May 13, 2024

Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men.

Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian Men.

Journal: Journal of the National Comprehensive Cancer Network : JNCCN

Published: May 01, 2024

Re: Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.

Re: Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.

Journal: European urology

Published: April 27, 2024

Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.

Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression.

Journal: Oncoimmunology

Published: March 15, 2024

Showing 1-12 of 197

Last Updated: 09/26/2026